)
)
){kind=logo}
Eric Fung
SVP - Clinical Development
,
GRAIL
Eric Fung, MD, PhD, leads several clinical development programs in support of the development of a blood-based multi-cancer detection test. Dr. Fung has previously held clinical development and R&D leadership roles at Affymetrix, Vermillion, Ciphergen, and Roche Molecular Diagnostics. Dr. Fung has led clinical trials leading to FDA clearance of multiple IVD products. Dr. Fung received his MD, PhD from the Johns Hopkins University School of Medicine.
Sessions
-
The Economics of Early Detection: Transforming Cancer Risk into Insurable Opportunity15-Oct-2025ITC Life, Health & Benefits Stage (Expo Floor)